drugset / Trial / NCT04360005

Managed Access Programs for ABL001, Asciminib

NCT04360005

Expanded access Available Novartis Pharmaceuticals

Summary

The purpose of this registration form is to list all Managed Access Programs (MAPs) related to ABL001, asciminib

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Asciminib Unknown